318 related articles for article (PubMed ID: 33183433)
21. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
22. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
23. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
Li JL; Zheng CL; Liu JP; Zhu JB
Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
[TBL] [Abstract][Full Text] [Related]
24. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects.
Tahara K; Yamamoto H; Hirashima N; Kawashima Y
Eur J Pharm Biopharm; 2010 Mar; 74(3):421-6. PubMed ID: 20034563
[TBL] [Abstract][Full Text] [Related]
25. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
26. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.
Emami J; Maghzi P; Hasanzadeh F; Sadeghi H; Mirian M; Rostami M
Pharm Dev Technol; 2018 Jan; 23(1):41-54. PubMed ID: 28608760
[TBL] [Abstract][Full Text] [Related]
27. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
28. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.
Zeng P; Xu Y; Zeng C; Ren H; Peng M
Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597
[TBL] [Abstract][Full Text] [Related]
29. Microfluidic-assisted preparation of PLGA nanoparticles loaded with insulin: a comparison with double emulsion solvent evaporation method.
Kouhjani M; Jaafari MR; Kamali H; Abbasi A; Tafaghodi M; Mousavi Shaegh SA
J Biomater Sci Polym Ed; 2024 Feb; 35(3):306-329. PubMed ID: 38100556
[TBL] [Abstract][Full Text] [Related]
30. Dual drug loaded PLGA nanospheres for synergistic efficacy in breast cancer therapy.
Deepika MS; Thangam R; Sheena TS; Vimala RTV; Sivasubramanian S; Jeganathan K; Thirumurugan R
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109716. PubMed ID: 31349431
[TBL] [Abstract][Full Text] [Related]
31. Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-D-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy.
Chu Q; Xu H; Gao M; Guan X; Liu H; Deng S; Huo X; Liu K; Tian Y; Ma X
Int J Nanomedicine; 2016; 11():449-63. PubMed ID: 26869788
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic Effects of Paclitaxel Loaded Polyethylene Glycol-Polylactic Acid-Glycolic Acid Copolymer Nanoparticles on Pancreatic Cancer in Rats.
Fu Y; Tan L; Meng L; Lei X
J Nanosci Nanotechnol; 2020 Dec; 20(12):7271-7275. PubMed ID: 32711590
[TBL] [Abstract][Full Text] [Related]
33. Oleanolic acid-loaded PLGA-TPGS nanoparticles combined with heparin sodium-loaded PLGA-TPGS nanoparticles for enhancing chemotherapy to liver cancer.
Gao M; Xu H; Bao X; Zhang C; Guan X; Liu H; Lv L; Deng S; Gao D; Wang C; Tian Y
Life Sci; 2016 Nov; 165():63-74. PubMed ID: 27640889
[TBL] [Abstract][Full Text] [Related]
34. PLGA nanoparticles containing α-fetoprotein siRNA induce apoptosis and enhance the cytotoxic effects of doxorubicin in human liver cancer cell line.
Pho-Iam T; Punnakitikashem P; Somboonyosdech C; Sripinitchai S; Masaratana P; Sirivatanauksorn V; Sirivatanauksorn Y; Wongwan C; Nguyen KT; Srisawat C
Biochem Biophys Res Commun; 2021 May; 553():191-197. PubMed ID: 33774221
[TBL] [Abstract][Full Text] [Related]
35. Zinc phthalocyanine tetrasulfonate-loaded polyelectrolytic PLGA nanoparticles for photodynamic therapy applications.
de Toledo MCMC; Abreu ADS; Carvalho JA; Ambrósio JAR; Godoy DDS; Dos Santos Pinto BC; Beltrame Junior M; Simioni AR
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101966. PubMed ID: 32835878
[TBL] [Abstract][Full Text] [Related]
36. Poly(L-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA.
Jeon O; Lim HW; Lee M; Song SJ; Kim BS
J Drug Target; 2007 Apr; 15(3):190-8. PubMed ID: 17454356
[TBL] [Abstract][Full Text] [Related]
37. A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment.
Bao X; Gao M; Xu H; Liu KX; Zhang CH; Jiang N; Chu QC; Guan X; Tian Y
Drug Dev Ind Pharm; 2015; 41(7):1193-203. PubMed ID: 25026246
[TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
[TBL] [Abstract][Full Text] [Related]
39. Fabrication and evaluation of artemether loaded polymeric nanorods obtained by mechanical stretching of nanospheres.
Bhide AR; Jindal AB
Int J Pharm; 2021 Aug; 605():120820. PubMed ID: 34166728
[TBL] [Abstract][Full Text] [Related]
40. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer.
Bhatt K; Patil P; Jani P; Thakkar P; Sawant K
Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
